1. Home
  2. BCLI vs CMLS Comparison

BCLI vs CMLS Comparison

Compare BCLI & CMLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
  • CMLS
  • Stock Information
  • Founded
  • BCLI 2000
  • CMLS N/A
  • Country
  • BCLI United States
  • CMLS United States
  • Employees
  • BCLI N/A
  • CMLS N/A
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • CMLS Broadcasting
  • Sector
  • BCLI Health Care
  • CMLS Consumer Discretionary
  • Exchange
  • BCLI Nasdaq
  • CMLS Nasdaq
  • Market Cap
  • BCLI 37.7M
  • CMLS 32.8M
  • IPO Year
  • BCLI N/A
  • CMLS 1998
  • Fundamental
  • Price
  • BCLI $0.42
  • CMLS $2.09
  • Analyst Decision
  • BCLI Strong Buy
  • CMLS Buy
  • Analyst Count
  • BCLI 1
  • CMLS 3
  • Target Price
  • BCLI $2.00
  • CMLS $11.00
  • AVG Volume (30 Days)
  • BCLI 812.3K
  • CMLS 25.4K
  • Earning Date
  • BCLI 08-12-2024
  • CMLS 07-26-2024
  • Dividend Yield
  • BCLI N/A
  • CMLS N/A
  • EPS Growth
  • BCLI N/A
  • CMLS N/A
  • EPS
  • BCLI N/A
  • CMLS N/A
  • Revenue
  • BCLI N/A
  • CMLS $838,909,000.00
  • Revenue This Year
  • BCLI N/A
  • CMLS $2.39
  • Revenue Next Year
  • BCLI N/A
  • CMLS N/A
  • P/E Ratio
  • BCLI N/A
  • CMLS N/A
  • Revenue Growth
  • BCLI N/A
  • CMLS N/A
  • 52 Week Low
  • BCLI $0.13
  • CMLS $1.78
  • 52 Week High
  • BCLI $2.06
  • CMLS $6.59
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 53.54
  • CMLS 50.84
  • Support Level
  • BCLI $0.33
  • CMLS $1.78
  • Resistance Level
  • BCLI $0.38
  • CMLS $2.08
  • Average True Range (ATR)
  • BCLI 0.04
  • CMLS 0.12
  • MACD
  • BCLI 0.01
  • CMLS 0.04
  • Stochastic Oscillator
  • BCLI 81.82
  • CMLS 67.39

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About CMLS Cumulus Media Inc.

Cumulus Media Inc is an audio-first media company delivering content to over a quarter billion people every month wherever and whenever required. It is a radio broadcasting company combining high-quality local programming with iconic, nationally syndicated media, sports, and entertainment brands to deliver premium content choices to its customers and radio stations affiliated with Westwood One network and numerous digital channels. The company's revenue is derived mainly from the sale of local, regional, and national advertising which is broadcast on its radio stations.

Share on Social Networks: